Form 4 for NHI NATIONAL HEALTH INVESTORS INC
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001127602-25-008401 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | NHI | Spaid John L | CFO, EVP Fin | A - Grant | $0.00 | +6,500 | 44.7K | +17% | $0 |
| DM | 2025-03-05 | 2025-03-03 | NHI | Spaid John L | CFO, EVP Fin | A - Grant | $0.00 | +45.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | A | A | 6,500 | $0.00 | 44,682.64 | D | — | — | (F1) These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting March 3, 2026 |
| 2 | Derivative | Stock Option (Right to Buy) 2025 | 2025-03-03 | A | A | 15,000 | $0.00 | 15,000 | D | $73.34 · 2027-03-03 to 2030-03-03 | 15,000 Common Stock | |
| 3 | Derivative | Stock Option (Right to Buy) 2025 | 2025-03-03 | A | A | 15,000 | $0.00 | 15,000 | D | $73.34 · 2025-03-03 to 2030-03-03 | 15,000 Common Stock | |
| 4 | Derivative | Stock Option (Right to Buy) 2025 | 2025-03-03 | A | A | 15,000 | $0.00 | 15,000 | D | $73.34 · 2026-03-03 to 2030-03-03 | 15,000 Common Stock |